Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pharming Group N.V (PHAR) Prepaid Assets: 2021-2025

Historic Prepaid Assets for Pharming Group N.V (PHAR) over the last 4 years, with Sep 2025 value amounting to $95,000.

  • Pharming Group N.V's Prepaid Assets rose 2.15% to $95,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $95,000, marking a year-over-year increase of 2.15%. This contributed to the annual value of $90,000 for FY2024, which is 2.17% down from last year.
  • Latest data reveals that Pharming Group N.V reported Prepaid Assets of $95,000 as of Q3 2025, which was down 0.00% from $95,000 recorded in Q2 2025.
  • Pharming Group N.V's 5-year Prepaid Assets high stood at $238,000 for Q1 2022, and its period low was $88,000 during Q3 2023.
  • In the last 3 years, Pharming Group N.V's Prepaid Assets had a median value of $92,500 in 2023 and averaged $106,000.
  • As far as peak fluctuations go, Pharming Group N.V's Prepaid Assets climbed by 17.53% in 2022, and later plummeted by 61.37% in 2024.
  • Over the past 5 years, Pharming Group N.V's Prepaid Assets (Quarterly) stood at $194,000 in 2021, then climbed by 17.53% to $228,000 in 2022, then plummeted by 59.65% to $92,000 in 2023, then dropped by 2.17% to $90,000 in 2024, then climbed by 2.15% to $95,000 in 2025.
  • Its Prepaid Assets stands at $95,000 for Q3 2025, versus $95,000 for Q2 2025 and $94,000 for Q1 2025.